588 related articles for article (PubMed ID: 16184571)
1. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
Stärkel P; Stoffel M; Lerut J; Horsmans Y
Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
[TBL] [Abstract][Full Text] [Related]
2. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
Rosenau J; Hooman N; Hadem J; Rifai K; Bahr MJ; Philipp G; Tillmann HL; Klempnauer J; Strassburg CP; Manns MP
Liver Transpl; 2007 Mar; 13(3):367-73. PubMed ID: 17318859
[TBL] [Abstract][Full Text] [Related]
3. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
[TBL] [Abstract][Full Text] [Related]
4. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
Sánchez-Fueyo A; Rimola A; Grande L; Costa J; Mas A; Navasa M; Cirera I; Sánchez-Tapias JM; Rodés J
Hepatology; 2000 Feb; 31(2):496-501. PubMed ID: 10655276
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
Kwon CH; Suh KS; Yi NJ; Chang SH; Cho YB; Cho JY; Lee HJ; Seo JK; Lee KU
Pediatr Transplant; 2006 Jun; 10(4):479-86. PubMed ID: 16712607
[TBL] [Abstract][Full Text] [Related]
7. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
8. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
[TBL] [Abstract][Full Text] [Related]
9. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
Rosenau J; Kreutz T; Kujawa M; Bahr MJ; Rifai K; Hooman N; Finger A; Michel G; Nashan B; Kuse ER; Klempnauer J; Tillmann HL; Manns MP
J Hepatol; 2007 Apr; 46(4):635-44. PubMed ID: 17316869
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.
Usui M; Sugimoto K; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Takei Y; Isaji S
Transplant Proc; 2016 May; 48(4):1179-83. PubMed ID: 27320582
[TBL] [Abstract][Full Text] [Related]
11. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
Wadhawan M; Gupta S; Goyal N; Taneja S; Kumar A
Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients.
Park JB; Kwon CH; Lee KW; Choi GS; Kim DJ; Seo JM; Kim SJ; Joh JW; Lee SK
Transpl Int; 2008 Apr; 21(4):346-52. PubMed ID: 18208419
[TBL] [Abstract][Full Text] [Related]
13. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
[TBL] [Abstract][Full Text] [Related]
14. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease.
Bienzle U; Günther M; Neuhaus R; Vandepapeliere P; Vollmar J; Lun A; Neuhaus P
Hepatology; 2003 Oct; 38(4):811-9. PubMed ID: 14512868
[TBL] [Abstract][Full Text] [Related]
15. Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?
van Nunen AB; de Man RA; Heijtink RA; Vossen AC; Schalm SW
J Viral Hepat; 2002 May; 9(3):221-8. PubMed ID: 12010511
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results.
Albeniz Arbizu E; Barcena Marugan R; Oton Nieto E; Carrera Alonso E; Garcia Gonzalez M; Moreno Garcia J; de Vicente Lopez E; Nuño Vazquez-Garza J; Martin Davila P
Transplant Proc; 2003 Aug; 35(5):1848-9. PubMed ID: 12962820
[TBL] [Abstract][Full Text] [Related]
17. HBIg discontinuation with maintenance oral anti-viral therapy and HBV vaccination in liver transplant recipients.
Weber NK; Forman LM; Trotter JF
Dig Dis Sci; 2010 Feb; 55(2):505-9. PubMed ID: 19802696
[TBL] [Abstract][Full Text] [Related]
18. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
[TBL] [Abstract][Full Text] [Related]
19. Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant.
Tandoi F; Nada E; Pittaluga F; Fop F; Lupo F; Romagnoli R; Salizzoni M
Transplant Proc; 2014 Sep; 46(7):2308-11. PubMed ID: 25242775
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report.
Alonso I; Herreros de Tejada A; Moreno JM; Rubio E; Lucena JL; De la Revilla J; Sánchez Turrión V; Gomez A; Lopez J; Cuervas-Mons V
Transplant Proc; 2003 Aug; 35(5):1850-1. PubMed ID: 12962821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
